Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
25 Jun 2019
Historique:
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 17 1 2020
Statut: epublish

Résumé

Compared with the general population, rates of pheochromocytoma are higher in neurofibromatosis type 1 (NF1) patients. However, pheochromocytoma testing is often plagued by false positive results. Here we present a patient with NF1, elevated urinary metanephrine levels, and an indeterminate adrenal nodule. Clonidine suppression testing aided diagnosis and led to definitive surgical treatment that confirmed a pheochromocytoma. Pheochromocytoma screening and clonidine suppression testing can both aid in the evaluation for catecholamine-secreting tumours.

Identifiants

pubmed: 31243023
pii: 12/6/e228263
doi: 10.1136/bcr-2018-228263
pmc: PMC6605898
pii:
doi:

Substances chimiques

Adrenergic alpha-2 Receptor Agonists 0
Metanephrine 5001-33-2
Clonidine MN3L5RMN02

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin Endocrinol (Oxf). 2007 May;66(5):703-8
pubmed: 17388796
J Neurosci Rural Pract. 2012 Jan;3(1):107-8
pubmed: 22346222
Clin Diabetes Endocrinol. 2018 Jun 22;4:15
pubmed: 29977594
J Hum Hypertens. 2011 Jul;25(7):451-6
pubmed: 20811397
Open Access Maced J Med Sci. 2015 Dec 15;3(4):713-6
pubmed: 27275314
SAGE Open Med Case Rep. 2017 Nov 16;5:2050313X17741016
pubmed: 29201372
J Nucl Med. 1994 Jul;35(7):1138-44
pubmed: 8014671
J Clin Endocrinol Metab. 2003 Jun;88(6):2656-66
pubmed: 12788870
Eur J Endocrinol. 2016 Oct;175(4):335-44
pubmed: 27450695
Indian J Endocrinol Metab. 2011 Oct;15 Suppl 4:S406-8
pubmed: 22145148
Adv Chronic Kidney Dis. 2015 May;22(3):218-23
pubmed: 25908471
Oncol Lett. 2016 Jul;12(1):637-643
pubmed: 27347193
J Clin Endocrinol Metab. 2003 Oct;88(10):4533-9
pubmed: 14557417
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
World J Surg Oncol. 2010 Mar 10;8:14
pubmed: 20219130
Indian J Endocrinol Metab. 2013 Mar;17(2):349-51
pubmed: 23776920

Auteurs

WingYee Wan (W)

Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.

Bichle Nguyen (B)

Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.

Sky Graybill (S)

Endocrinology Department, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.

Jonathan Kim (J)

Internal Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH